Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-04-15

Clinical Trial Update: Isoleucine Addition Treatment Effects in a Controlled Diet Study [NA]

View source ↗

Summary

A clinical trial evaluating the addition of the amino acid isoleucine to a controlled diet for individuals with prediabetes and metabolic syndrome has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoleucine (L-isoleucine)

Snippet

Sponsor: Jean L. Fry | Conditions: Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS) | NA | Status: WITHDRAWN